Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model
Crossref DOI link: https://doi.org/10.1038/srep44545
Published Online: 2017-03-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Öztürk Akcora, Büsra
Storm, Gert
Prakash, Jai
Bansal, Ruchi
Text and Data Mining valid from 2017-03-14
Version of Record valid from 2017-03-14
Article History
Received: 3 October 2016
Accepted: 10 February 2017
First Online: 14 March 2017
Competing interests
: The authors declare no competing financial interests.